Literature DB >> 24632887

Original research: using guided imagery to manage pain in young children with sickle cell disease.

Cassandra Elaine Dobson1, Mary Woods Byrne.   

Abstract

BACKGROUND: Despite innovations in treatment, disease-related pain is still the primary cause of hospitalization for children with sickle cell disease. Pharmacologic pain management relieves pain temporarily, but adverse effects are increasingly a concern. Cognitive behavioral therapies, which include the use of guided imagery, have shown promise in changing pain perception and coping patterns in people with chronic illnesses. Few studies have been done in children with sickle cell disease.
OBJECTIVES: The purposes of this study were to test the effects of guided imagery training on school-age children who had been diagnosed with sickle cell disease, and to describe changes in pain perception, analgesic use, self-efficacy, and imaging ability from the month before to the month after training.
METHODS: A quasi-experimental interrupted time-series design was used with a purposive sample of 20 children ages six to 11 years enrolled from one sickle cell disease clinic, where they had been treated for at least one year. Children completed pain diaries daily for two months, and investigators measured baseline and end-of-treatment imaging ability and self-efficacy.
RESULTS: After training in the use of guided imagery, participants reported significant increases in self-efficacy and reductions in pain intensity, and use of analgesics decreased as well.
CONCLUSIONS: Guided imagery is an effective technique for managing and limiting sickle cell disease-related pain in a pediatric population.

Entities:  

Mesh:

Year:  2014        PMID: 24632887     DOI: 10.1097/01.NAJ.0000445680.06812.6a

Source DB:  PubMed          Journal:  Am J Nurs        ISSN: 0002-936X            Impact factor:   2.220


  7 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  Sickle Cell Disease: A Review of Nonpharmacological Approaches for Pain.

Authors:  Hants Williams; Paula Tanabe
Journal:  J Pain Symptom Manage       Date:  2015-11-17       Impact factor: 3.612

3.  Opioid Prescription Filling Trends Among Children with Sickle Cell Disease After the Release of State-Issued Guidelines on Pain Management.

Authors:  Susan E Creary; Deena J Chisolm; Sharon K Wrona; Jennifer N Cooper
Journal:  Pain Med       Date:  2020-10-01       Impact factor: 3.750

4.  Opioid Use in Adults With Sickle Cell Disease Hospitalized During Vaso-Occlusive Crisis: A Systematic Review.

Authors:  Jennel C Osborne; Zainab Osakwe; Michelle Odlum
Journal:  J Hematol       Date:  2021-04-27

5.  Do chronic pain and comorbidities affect brain function in sickle cell patients? A systematic review of neuroimaging and treatment approaches.

Authors:  Joyce T Da Silva; Janelle E Letzen; Jennifer A Haythornthwaite; Patrick H Finan; Claudia M Campbell; David A Seminowicz
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

Review 6.  Pain in sickle cell disease: current and potential translational therapies.

Authors:  Varun Sagi; Aditya Mittal; Huy Tran; Kalpna Gupta
Journal:  Transl Res       Date:  2021-03-09       Impact factor: 10.171

Review 7.  Epigenetic Mechanisms of Integrative Medicine.

Authors:  Riya R Kanherkar; Susan E Stair; Naina Bhatia-Dey; Paul J Mills; Deepak Chopra; Antonei B Csoka
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-21       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.